Is UNII-30OMY4G3MK Safe in Breastfeeding
Question
I am a breastfeeding mother and i want to know if it is safe to use UNII-30OMY4G3MK? Is UNII-30OMY4G3MK safe for nursing mother and child? Does UNII-30OMY4G3MK extracts into breast milk? Does UNII-30OMY4G3MK has any long term or short term side effects on infants? Can UNII-30OMY4G3MK influence milk supply or can UNII-30OMY4G3MK decrease milk supply in lactating mothers?
UNII-30OMY4G3MK lactation summary
- DrLact safety Score for UNII-30OMY4G3MK is 3 out of 8 which is considered Low Risk as per our analyses.
- A safety Score of 3 indicates that usage of UNII-30OMY4G3MK may cause some minor side effects in breastfed baby.
- Our study of different scientific research indicates that UNII-30OMY4G3MK may cause moderate to no side effects in lactating mother.
- Most of scientific studies and research papers declaring usage of UNII-30OMY4G3MK low risk in breastfeeding are based on normal dosage and may not hold true for higher dosage.
- While using UNII-30OMY4G3MK We suggest monitoring child for possible reactions. It is also important to understand that side effects vary largely based on age of breastfed child and time of medication in addition to dosage.
- Score calculated using the DrLact safety Version 1.2 model, this score ranges from 0 to 8 and measures overall safety of drug in lactation. Scores are primarily calculated using publicly available case studies, research papers, other scientific journals and publically available data.
Answer by Dr. Ru: About UNII-30OMY4G3MK usage in lactation
Not commercially available in Spain
Answer by DrLact: About UNII-30OMY4G3MK usage in lactation
Because no information is available on the use of UNII-30OMY4G3MK during breastfeeding and its possible negative effects on lactation, other agents may be preferred, especially while nursing a newborn or preterm infant.
UNII-30OMY4G3MK Possible Effects in Breastfeeding
Published information on the effects of UNII-30OMY4G3MK on serum prolactin or on lactation in nursing mothers was not found as of the revision date. UNII-30OMY4G3MK decreases basal serum prolactin in men and nonnursing women. Serum prolactin continues to decrease for at least 7 years during continuous use.[1] The prolactin level in a mother with established lactation may not affect her ability to breastfeed.
Alternate Drugs
Brimonidine(Safe)
Guanfacine(Low Risk)
Methyldopa(Safe)
Trandolapril(Dangerous)
Chlorthalidone(Dangerous)
Propranolol(Safe)
Methyldopa(Safe)
Torsemide(Low Risk)
Chlorothiazide(Safe)
Losartan(Low Risk)
Spironolactone(Safe)
Captopril(Safe)
Lisinopril(Low Risk)
Irbesartan(Unsafe)
Reserpine(Unsafe)
Bumetanide(Low Risk)
Nadolol(Unsafe)
Isradipine(Low Risk)
Ramipril(Low Risk)
Metoprolol(Safe)
Indapamide(Low Risk)
Eprosartan(Low Risk)
Bendroflumethiazide(Unsafe)
Doxazosin(Safe)
Benazepril(Safe)
Levobunolol(Low Risk)
Hydrochlorothiazide(Safe)
Amlodipine(Low Risk)
Labetalol(Safe)
Hydralazine(Safe)
Nitrendipine(Safe)
Bosentan(Low Risk)
Furosemide(Low Risk)
Nisoldipine(Low Risk)
Carvedilol(Low Risk)
Fosinopril(Low Risk)
Nimodipine(Safe)
Nebivolol(Unsafe)
Bisoprolol(Low Risk)
Felodipine(Low Risk)
Guanfacine(Low Risk)
Nifedipine(Safe)
Valsartan(Low Risk)
Atenolol(Unsafe)
Enalapril(Safe)
Terazosin(Unsafe)
Acebutolol(Unsafe)
Diltiazem(Safe)
Nicardipine(Safe)
Minoxidil(Safe)
Telmisartan(Unsafe)
Verapamil(Safe)
Timolol(Safe)
Prazosin(Unsafe)
Sotalol(Low Risk)